TCG Crossover Management, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001839948 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 14, 2023

Total Value: $610M (100.0% shares, 0.0% debt)

Holdings (22)

— IVERIC BIO INC 15.8%

Value $96.34M Shares 2,448,829 Est. Cost $17.57 Unrealized —

GERN GERON CORP 12.4%

Value $75.72M Shares 23,589,779 Est. Cost $1.89 Unrealized +50.9%

COGT COGENT BIOSCIENCES INC 10.9%

Value $66.67M Shares 5,631,042 Est. Cost $9.54 Unrealized +20.2%

— VECTIVBIO HOLDING AG 8.7%

Value $52.93M Shares 3,113,600 Est. Cost $8.63 Unrealized —

— AEROVATE THERAPEUTICS INC 6.2%

Value $37.75M Shares 2,201,274 Est. Cost $15.75 Unrealized —

— ICOSAVAC, INC 6.0%

Value $36.78M Shares 3,703,704 Est. Cost $9.93 Unrealized —

MDGL MADRIGAL PHARMACEUTICALS INC 5.7%

Value $34.63M Shares 149,917 Est. Cost $94.85 Unrealized +185.5%

TYRA TYRA BIOSCIENCES INC 5.6%

Value $33.87M Shares 1,989,103 Est. Cost $12.71 Unrealized +14.2%

KALV KALVISTA PHARMACEUTICALS, INC 5.0%

Value $30.56M Shares 3,395,495 Est. Cost $5.36 Unrealized +72.1%

VTYX VENTYX BIOSCIENCES, INC 4.4%

Value $26.76M Shares 815,724 Est. Cost $29.94 Unrealized +15.1%

DYN DYNE THERAPEUTICS, INC 3.0%

Value $18.56M Shares 1,650,150 Est. Cost $12.99 Unrealized -9.2%

KURA KURA ONCOLOGY INC 2.5%

Value $15.06M Shares 1,423,642 Est. Cost $14.54 Unrealized -18.7%

GPCR STRUCTURE THERAPEUTICS INC 2.4%

Value $14.55M Shares 350,000 Est. Cost $23.79 Unrealized —

IMVT IMMUNOVANT, INC 2.0%

Value $12.42M Shares 654,853 Est. Cost $12.59 Unrealized +48.1%

SLN SILENCE THERAPEUTICS PLC 1.9%

Value $11.58M Shares 2,104,875 Est. Cost $10.03 Unrealized —

ANTX AN2 Therapeutics, Inc. 1.8%

Value $10.96M Shares 1,289,320 Est. Cost $7.19 Unrealized 0.0%

TRDA ENTRADA THERAPEUTICS INC 1.5%

Value $8.856M Shares 584,955 Est. Cost $17.12 Unrealized —

— MERUS BV 1.3%

Value $7.899M Shares 300,000 Est. Cost $30.46 Unrealized —

CABA CABALETTA BIO, INC 1.0%

Value $6.285M Shares 486,795 Est. Cost $3.64 Unrealized +198.1%

ACRS ACLARIS THERAPEUTICS INC 0.9%

Value $5.494M Shares 529,839 Est. Cost $15.07 Unrealized -39.9%

CCCC C4 THERAPEUTICS, INC. 0.6%

Value $3.511M Shares 1,276,574 Est. Cost $5.83 Unrealized -44.9%

— ALPINE IMMUNE SCIENCES INC 0.4%

Value $2.602M Shares 253,069 Est. Cost $13.85 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	IVERIC BIO INC	2,448,829	$96.34M	15.8%	$17.57	—	COMM	46583P102
GERN	GERON CORP	23,589,779	$75.72M	12.4%	$1.89	+50.9%	COMM	374163103
COGT	COGENT BIOSCIENCES INC	5,631,042	$66.67M	10.9%	$9.54	+20.2%	COMM	19240Q201
—	VECTIVBIO HOLDING AG	3,113,600	$52.93M	8.7%	$8.63	—	COMM	H9060V101
—	AEROVATE THERAPEUTICS INC	2,201,274	$37.75M	6.2%	$15.75	—	COMM	008064107
—	ICOSAVAC, INC	3,703,704	$36.78M	6.0%	$9.93	—	COMM	45114M109
MDGL	MADRIGAL PHARMACEUTICALS INC	149,917	$34.63M	5.7%	$94.85	+185.5%	COMM	558868105
TYRA	TYRA BIOSCIENCES INC	1,989,103	$33.87M	5.6%	$12.71	+14.2%	COMM	90240B106
KALV	KALVISTA PHARMACEUTICALS, INC	3,395,495	$30.56M	5.0%	$5.36	+72.1%	COMM	483497103
VTYX	VENTYX BIOSCIENCES, INC	815,724	$26.76M	4.4%	$29.94	+15.1%	COMM	92332V107
DYN	DYNE THERAPEUTICS, INC	1,650,150	$18.56M	3.0%	$12.99	-9.2%	COMM	26818M108
KURA	KURA ONCOLOGY INC	1,423,642	$15.06M	2.5%	$14.54	-18.7%	COMM	50127T109
GPCR	STRUCTURE THERAPEUTICS INC	350,000	$14.55M	2.4%	$23.79	—	ADRS	86366E106
IMVT	IMMUNOVANT, INC	654,853	$12.42M	2.0%	$12.59	+48.1%	COMM	45258J102
SLN	SILENCE THERAPEUTICS PLC	2,104,875	$11.58M	1.9%	$10.03	—	ADRS	82686Q101
ANTX	AN2 Therapeutics, Inc.	1,289,320	$10.96M	1.8%	$7.19	0.0%	COMM	037326105
TRDA	ENTRADA THERAPEUTICS INC	584,955	$8.856M	1.5%	$17.12	—	COMM	29384C108
—	MERUS BV	300,000	$7.899M	1.3%	$30.46	—	COMM	N5749R100
CABA	CABALETTA BIO, INC	486,795	$6.285M	1.0%	$3.64	+198.1%	COMM	12674W109
ACRS	ACLARIS THERAPEUTICS INC	529,839	$5.494M	0.9%	$15.07	-39.9%	COMM	00461U105
CCCC	C4 THERAPEUTICS, INC.	1,276,574	$3.511M	0.6%	$5.83	-44.9%	COMM	12529R107
—	ALPINE IMMUNE SCIENCES INC	253,069	$2.602M	0.4%	$13.85	—	COMM	02083G100